Skip to main content
. Author manuscript; available in PMC: 2017 Dec 11.
Published in final edited form as: Pharm Res. 2014 May 29;31(10):2796–2809. doi: 10.1007/s11095-014-1377-4

Fig. 7.

Fig. 7

Effects of NDDs and ENDDs on metastatic H1650 lung tumor weight (a); tumor volume (b); mice body weight (c). Lung weights and tumor volumes were determined for measurement of therapeutic activity of the treatments. Control group received blank ENDDs only. (p<0.05, statistical significance of the difference in tumor volume/weight of treatment groups) (*, significantly different from controls, NDi and NDo; **, significantly different from NDDs). Data presented are means and SD (n=6). This experiment was repeated twice.